New clues to help diabetes and hypoglycemia

September 26, 2002

Australian scientists have found clues to why patients with insulin-dependent diabetes are often unable to sense their need to take life-saving glucose.

The evidence came from a known and potent appetite stimulant released by the brain called Neuropeptide Y (NPY). Studies using diabetic rats have shown the NPY levels in the brains of diabetic rats differ significantly to those of normal rats under conditions of low glucose.

It was known that specific nerves in the brain sense the levels of glucose in the body.

"But how these nerves operate and how the brain tells us we need to eat or we are full, which can help maintain glucose levels, has remained a mystery. Understanding these mechanisms is a major goal of diabetes research," says University of Melbourne pharmacologist, Associate Professor Margaret Morris who led the research.

"Our research has provided some insight into these mechanisms and should lead to a better understanding and, ultimately, management of diabetes and hypoglycemia, the life threatening condition faced by diabetics when their blood glucose gets too low," she says.

The study is published in the latest edition of Diabetologia and is supported by the Juvenile Diabetes Research Foundation, the world's largest funder of research into diabetes.

Previous clinical research had shown that a long-term program of multiple daily insulin injections can protect against the complications of type-1 diabetes such as blindness and kidney failure. The aim of the program is to drive down the high blood glucose levels, characteristic of diabetes, closer to that of non-diabetic individuals.

Normally we keep a relatively constant level of blood glucose by the pancreas constantly adjusting the amount of insulin it releases. A diabetes, blood sugar can only be controlled by injections of insulin. This causes a series of highs and lows in blood glucose. The problem with such an intensive program of insulin injection is that the lows experienced can often be too low placing the person at risk of hypoglycemia.

Studies have shown that people with repeated exposure to hypoglycemic conditions become desensitised to the body's triggers that inform us we are in this predicament. In the case of NPY, this trigger would be the desire to eat, which would restore blood sugar levels.

The University of Melbourne study compared diabetic and normal rats' brain responses after periods of low glucose, and then tested their ability to recover upon return to normal glucose levels.

The production of NPY in diabetic rats fell significantly during the period of low glucose. In contrast, the NPY levels in the normal rat remained unchanged.

A second approach looked at the levels of NPY in response to injections of insulin. This time the effects in the two groups were opposite. The normally high NPY levels in the diabetic rat decreased, while normally low NPY levels in the normal rat increased.

"As insulin lowers the blood glucose levels, a response that would normally trigger the desire to eat, it is strange that the NPY levels in diabetic rats drop, an effect that would normally suppress the need to eat," says Morris.

"We know that NPY is linked to the brains ability to sense and control the body's levels of glucose. Our task now is to understand NPY's exact role, why it differs in diabetes, what nerves are involved and what, if any, other sensory nerves and stimulants are involved," she says.
-end-
JDRF has just provided an additional US$55,000 to fund this research.

University of Melbourne

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.